We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KKR:NYSEKKR & Co. Inc. Analysis

Data as of 2026-06-02 - not real-time

$95.01

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

KKR is trading near a key support level with the short‑term moving average modestly above the mid‑term average, while the long‑term average remains well above current prices, indicating a neutral to slightly bearish technical backdrop. The relative strength index sits in the mid‑range, suggesting neither strong momentum nor oversold conditions. Momentum indicators show a bearish divergence, as the MACD line trails its signal, and volume trends are declining, adding pressure on price. Volatility is elevated and the stock’s beta is high, reflecting sensitivity to broader market swings. Fundamental metrics reveal a price‑to‑earnings multiple that is substantially higher than the industry average, a modest dividend yield with a low payout ratio, and a balance sheet weighted heavily toward debt. Nonetheless, cash reserves are sizable, and recent earnings have beaten estimates, with fee‑related earnings per share accelerating year‑over‑year.
The latest quarter brought a surprise earnings beat, an expanded share‑repurchase program, and a modest dividend increase, all of which have been highlighted in analyst coverage as catalysts for near‑term upside. Investor sentiment is buoyant, as reflected by an extreme‑greed market mood indicator. The firm’s strategic move to open a new office in Milan underscores its commitment to deepen European exposure, potentially unlocking new deal flow. While the sector faces moderate regulatory scrutiny, KKR’s diversified global platform and focus on high‑growth industries provide a resilient earnings foundation. The combination of strong cash generation, attractive valuation relative to future earnings expectations, and ongoing capital return initiatives supports a favorable outlook. However, the high leverage and market volatility warrant caution, especially if broader risk sentiment shifts.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near technical support
  • bearish momentum signals
  • recent earnings beat and dividend increase

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • expanded buyback program
  • strong cash position offsetting leverage
  • growth opportunities from European expansion

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • sustainable dividend policy
  • high upside potential relative to current price
  • diversified global asset base in high‑growth sectors

Key Metrics & Analysis

Financial Health

Revenue Growth-6.60%
Profit Margin11.68%
P/E Ratio32.3
ROE7.66%
ROA1.46%
Debt/Equity69.03
P/B Ratio3.0
Op. Cash Flow$-325296000
Industry P/E16.6

Technical Analysis

TrendNeutral
RSI44.5
Support$91.08
Resistance$105.95
MA 20$97.45
MA 50$96.97
MA 200$115.75
MACDBearish
VolumeDecreasing
Fear & Greed Index92.64

Valuation

Target Price$125.64
Upside/Downside32.24%
GradeOvervalued
TypeBlend
Dividend Yield0.79%

Risk Assessment

Beta1.63
Volatility29.85%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.